Effect of Epidural Steroid Injection on Bone Mineral Density and Markers of Bone Turnover in Postmenopausal Women
Authors:
- D. Sudhaker RaoDRD. Sudhaker Rao
- Jennifer SchillingJSJennifer Schilling
- Edward PetersonEPEdward Peterson
- Shlomo MandelSMShlomo Mandel
- 1 December 2012
- journal article
- Published by Wolters Kluwer Health in Spine
- Vol. 37 (25) , E1567-E1571
Abstract
A prospective, observational study. To evaluate the effect of epidural steroid injection (ESI) on bone mineral density (BMD) in postmenopausal women. ESIs are used to treat the pain associated with radiculopathy. Although it is known that exogenous steroid use can disrupt skeletal architecture, it is less clear whether ESIs result in a decrease of BMD. Twenty-eight postmenopausal women experiencing radiculopathy elected L4-L5 ESI treatment. We had a 50% dropout rate due to noncompliance with study requirements. BMD of the hip, femoral neck, and spine along with markers of bone turnover, bone specific-alkaline phosphatase and serum C-telopeptide of collagen I (CTX), was evaluated at baseline preinjection and 3 and 6 months postinjection. There was a significant decline in the hip BMD of 0.018 g/cm (0.028 ± 0.007, P = 0.002) at 6 months compared with baseline. We compared this decline with an age-matched control population that exhibited a decline of 0.003 g/cm(2), significantly less than our study population (P = 0.007). Bone-specific alkaline phosphatase increased significantly by 2.33 U/L from 3 to 6 months (P = 0.012), but the rise of CTX was not significant. A single ESI in postmenopausal women adversely affects BMD of the hip. This is in conjunction with a rise in bone remodeling activity, as evidenced by an increase in bone-specific alkaline phosphatase and CTX. In addition, when compared with an age-matched control population, our study population exhibited a greater decline in BMD. Our findings show that epidural administration of corticosteroids has a deleterious effect on bone, which should be considered when contemplating treatment options for radiculopathy. The resulting decrease in BMD, while slight, suggests that ESIs should be used with caution in those at a risk for fracture.Keywords
This publication has 21 references indexed in Scilit:
- Effects of Epidural Steroid Injections on Blood Glucose Levels in Patients With Diabetes MellitusSpine, 2012
- Glucocorticoid-Induced Bone DiseaseNew England Journal of Medicine, 2011
- Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelinesThe Spine Journal, 2010
- Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment optionsDrug, Healthcare and Patient Safety, 2010
- Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2-Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230)Journal of Bone and Mineral Research, 2006
- Endocrine effects of aromatase inhibitors and inactivators in vivo: Review of data and method limitationsThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Comparison of Trabecular Bone Microarchitecture and Remodeling in Glucocorticoid-Induced and Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2001
- Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the study of osteoporotic fracturesJournal of Bone and Mineral Research, 1995
- Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugsJournal of Bone and Mineral Research, 1994
- Intestinal Calcium Absorption in Exogenous HypercortisonismJournal of Clinical Investigation, 1977